Santen Pharmaceutical Co., Ltd. (参天製薬株式会社, Santen Seiyaku Kabushiki-gaisha), is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.[3]
Santen Pharmaceutical Co., Ltd.
The company's Research and Development Center in Ikoma, Nara
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established.[4] In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products.[5]
santen, pharmaceutical, 参天製薬株式会社, santen, seiyaku, kabushiki, gaisha, japanese, pharmaceutical, company, specializing, ophthalmology, with, ophthalmic, products, santen, holds, share, within, japanese, market, leading, ophthalmic, companies, worldwide, with, p. Santen Pharmaceutical Co Ltd 参天製薬株式会社 Santen Seiyaku Kabushiki gaisha is a Japanese pharmaceutical company specializing in ophthalmology With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide with its products being sold in over 50 countries 3 Santen Pharmaceutical Co Ltd The company s Research and Development Center in Ikoma NaraNative name参天製薬株式会社Company typePublic KKTraded asTYO 4536OSE 4536IndustryPharmaceuticalFoundedOsaka Japan 1890 1890 FounderKenkichi TaguchiHeadquartersGrand Front Osaka Tower A 4 20 Ofuka cho Kita ku Osaka 530 8552 JapanKey peopleAkira Kurokawa CEO and President ProductsPharmaceuticalsMedical devicesRevenue 2 429 billion FY 2018 243 0 billion FY 2018 Net income 175 661 million FY 2012 16 521 billion FY 2012 Number of employees3 805 consolidated as of March 31 2018 WebsiteOfficial websiteFootnotes references 1 2 The company was founded in 1890 by Kenkichi Taguchi as Taguchi Santendo and in 1925 Santendo Co Ltd was established 4 In 2014 Santen announced that it has entered into an agreement with Merck amp Co to purchase Merck s ophthalmology products 5 Business locations editSanten has 3 plants located in Hōdatsushimizu Ishikawa in Tampere and in Suzhou 21 subsidiary companies located in Japan the US the Netherlands Finland United Kingdom amp Ireland Spain Switzerland Italy France 6 Germany Sweden China South Korea Taiwan India Thailand Malaysia the Philippines and Singapore Its R amp D center is located in Ikoma Nara 7 8 References edit Company Overview Santen Pharmaceutical Retrieved April 14 2014 Financial Highlights Santen Pharmaceutical Retrieved April 14 2014 Santen Announces Approval of DIQUASTM for Dry Eye Treatment in Japan Business Wire April 16 2010 Retrieved April 14 2014 Company History Santen Pharmaceutical Retrieved April 14 2014 McCarthy Colleen July 1 2014 Santen purchases ophthalmic assets from Merck Optometry Times UBM plc Retrieved March 1 2016 Japan s Santen plans to buy Novagali for Eur 100 mln Reuters September 28 2011 Retrieved April 14 2014 Global Operations Santen Pharmaceutical Retrieved April 14 2014 Santen Pharmaceutical Co Ltd Nara Research and Development Center in Japanese Kansai Science City Retrieved April 14 2014 External links editOfficial global website nbsp Japan portal nbsp Medicine portal nbsp Companies portal Retrieved from https en wikipedia org w index php title Santen Pharmaceutical amp oldid 1197702769, wikipedia, wiki, book, books, library,
